DIABETES AND THE KIDNEYS

Slides:



Advertisements
Similar presentations
Chronic kidney disease
Advertisements

Diabetes and Kidney Problems
Preventing Strokes One at a Time Acute Interventions and Management 2009.
Diabetic Nephropathy.  Over 40% of new cases of end-stage renal disease (ESRD) are attributed to diabetes.  In 2001, 41,312 people with diabetes began.
Hypertension NPN 200 Medical Surgical I. Description of Hypertension Intermittent or sustained elevation in the diastolic or systolic blood pressure:
CKD In Primary Care Dr Mohammed Javid.
National Institute for Health and Clinical Excellence.
DM & CKD Dr. Shahrzad Shahidi Professor of Nephrology Isfahan University of Medical Sciences.
RENAL BLOOD TESTS WHAT DO THEY MEAN, WHERE TO GO FOR WHAT TO DO.
Canadian Diabetes Association Clinical Practice Guidelines Chronic Kidney Disease in Diabetes Chapter 29 Phil McFarlane, Richard E. Gilbert, Lori MacCallum,
Assessment and Management of Patients With Hypertension.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
Hypertension Diagnosis and Treatment  Based on JNC 7 – published in 2003  Goal: BP
Canadian Diabetes Association Clinical Practice Guidelines Treatment of Hypertension Chapter 25 Richard E. Gilbert, Doreen Rabi, Pierre LaRochelle, Lawrence.
Lesley Stevens MD Tufts-New England Medical Center
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
By Jessica Davies. Angiotensin Converting Enzyme Inhibitors Used to help control Hypertension Also they help with heart failure, preventing strokes, and.
An Ounce of Prevention – Avoiding Complications
Diabetic Nephropathy Case Presentations. UA (Urine Dipstick) Use as an initial screen for all patients Negative to trace proteinuria requires further.
1 Diabetes Education Teaching Guide Kidney Health.
Early Detection and Prevention of Renal Failure Linda Fried, MD, MPH.
Microvascular complications Diabetes Outreach (August 2011)
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
Assessment, Targets, Thresholds and Treatment Bryan Williams NICE clinical guideline 127.
Rapid E clinical guidance in the management of Type 2 diabetes New Zealand Guidelines Group.
Criteria for Diagnosis of DM * Testing must be repeated on separate day. FPG is the preferred test ** Symptoms of DM IFG = Impaired fasting glucose IGT.
DIABETES 1 The Value of Screening: HbA1c as a Diagnostic Tool David Kendall, MD Chief Scientific and Medical Officer American Diabetes.
Diabetes Mellitus Ibrahim Sales, Pharm.D. Assistant Professor of Clinical Pharmacy King Saud University
Diabetes and Kidney. Diabetic Kidney Normal Kidney.
Section 6: Management in primary care Particular emphasis on nurse practitioner’s role.
PRE-EXISTING DIABETES AND PREGNANCY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
PEBB Board Presentation Kaiser 2006 Quality Initiatives.
Management of Type 2 Diabetes New Zealand Guidelines Group.
Standards of Medical Care for Patients with Diabetes Mellitus John Guzek, MD March 2003.
SHEFFIELD GUIDELINES: RENAL DISEASE IN DIABETES Dr Jenny Stephenson GP, Stannington Medical Centre
Shadi Al-Ahmadi. The Presentation will include: Hypertension Dyslipidemia CVD Type 2 Diabetes-Associated Retinopathy Diabetic Periphral Neuropathy Diabetic.
Diabetic nephropathy. Diabetic nephropathy- definition Chronic microangiopathy type complication of DM characterized by: 1. proteinuria 2. hypertension.
Diabetic Nephropathy in the Adolescent Age Group Henry Rodriguez, M.D. Associate Professor of Pediatrics Indiana University School of Medicine Director,
NICE GUIDELINES HYPERTENSION Masroor Syed. Latest Issue June 2006 Evidence Based uickrefguide.pdf
Diabetic Nephropathy.  Over 40% of new cases of end-stage renal disease (ESRD) are attributed to diabetes.  In 2001, 41,312 people with diabetes began.
Aminoglycoside-Induced Acute Tubular Necrosis PHCL 442 Lab Discussion 2 Raniah Al-Jaizani M.Sc.
Hypertension NICE CG127 August Hypertension is not a disease it is a risk factor for cardiovasuclar disease (CVD)-it is a modifiable risk factor.
Section 5: Configuration of healthcare to manage CKD.
Dr M Sivalingam Renal Unit, Lister Hospital, Stevenage.
Case Report and Lit Review: Reduction of Proteinuria in Diabetic Nephropathy with Spironolactone Harry W. Floyd, M.D. Family Medicine Kingstree, South.
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
Section IV. Routine and Optional Laboratory Tests for the Investigation of Patients with Hypertension 2015 Canadian Hypertension Education Program Recommendations.
2-4. Estimated Renal Function Estimated GFR = 1.8 x (Cs) x (age) Cockcroft-Gault eq. – Estimated creatine clearance (mL/min) = (140 – age x body weight,
Hypertension Control and Progression of Renal Disease
DIABETIC TEACHING VERMALYNPAULETTEMICHELLEEDWARD.
NICE/BHS Hypertension Guideline Review 28 June 2006 John Barker ESH Clinical Hypertension Specialists European Society of Hypertension Specialist Accreditation.
CHRONIC KIDNEY DISEASE
Michelle Gardner RN NUR-224. OBJECTIVES  Define normal blood pressure and categories of abnormal pressure  Identify risk factors for hypertension 
MACROVASCULAR COMPLICATIONS, DYSLIPIDEMIA and HYPERTENSION 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Diabetes And Hemodialysis 1 Dr.Ruba Nashawati. 2.
Treatment of Hypertension in Adults With Diabetes DR AMAL HARFOUSH.
Dr.Ruba Nashawati. Diabetes  Leading cause of ESRD  30% 40%  DN  DN Risk type I = type II.
Renal Complications Associated with Diabetes By Gabriella Benavides FNP-BC.
Circulation. 2014;129: Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy.
Risk Factors for Renal Dysfunction in Type 2 Diabetes: U.K. Prospective Diabetes Study 74 Ravi Retnakaran, Carole A Cull, Kerensa I Thorne, Amanda I Adler,
OPD follow up 1. General P/E Blood pressure Sites of insulin injection Deep tendon reflex 2.
Screening System for Hypertension and Diabetes at Primary Care Level
Diabetes Care Planning Interim Results
III. Endocrine Pancreas Diabetes Mellitus
Section 6: Management in primary care
Diabetes Health Status Report
Hypertension: A Risk Factor For Stroke
The Urinary System Lesson 2: Pathology of the Urinary System
Hypertension evaluation
Section 5: Configuration of healthcare to manage CKD
Presentation transcript:

DIABETES AND THE KIDNEYS Benita S. Padilla, M.D.

How does diabetes affect the kidneys? About 20% of diabetics will develop diabetic nephropathy The glomeruli become deposited with abnormal proteins, leading to inflammation and scarring Diabetic nephropathy leads to progressive deterioration in kidney function Diabetic nephropathy is now the leading cause of ESRD in our country

Can we do anything to help our patients avoid developing diabetic nephropathy? YES!! Optimal blood sugar control Optimal blood pressure control

Can we do anything to help our patients who already have diabetic nephropathy? YES!! First, we must diagnose diabetic nephropathy at the earliest possible time -before the patient develops symptoms

How do we make an early diagnosis of diabetic nephropathy? All diabetic patients should be screened for MICROALBUMINURIA MICRO – small amount of ALBUMIN URIA – in the urine Defined as urine albumin between 30 and 300 mg/day

When should a diabetic be screened for MA? For patients with type 1 DM 5 years after initial diagnosis of DM, then annually thereafter For patients with type 2 DM upon initial diagnosis of DM, then annually thereafter

How should screening for MA be done? MA cannot be detected by the ordinary urinalysis A positive test for protein in the routine urinalysis means that the patient has macroalbuminuria already Macroalbuminuria is defined as albumin excretion more than 300 mg/day

To review: Microalbuminuria 30 to 300 mg/day Macroalbuminuria >300 mg/day

How should screening for MA be done? Routine urinalysis (+) Protein? YES Patient has MACROalbuminuria NO YES Patient has MICROalbuminuria Micral test positive? NO Repeat within 3 mos to confirm Repeat after 1 yr

Be meticulous about blood sugar control How can the onset and progression of diabetic nephropathy be prevented? Be meticulous about blood sugar control Goals: FPG < 120 mg/dl (6.7 mmol/L), HbA1c < 7%) Be meticulous about blood pressure control Goal: BP < 130/80 mm Hg Every 10 mm reduction in SBP reduces by 12% the risk of any complication due to DM!

Be careful with your choice of antihypertensive medications How can the onset and progression of diabetic nephropathy be prevented? Be careful with your choice of antihypertensive medications ACE inhibitors and ARBs are the drugs of choice in patients with DN Screen for microalbuminuria ACE inhibitors and ARBs are recommended even if the patient is not hypertensive

How can the onset and progression of diabetic nephropathy be prevented? Discourage smoking strongly Educate the patient

What are the late signs of diabetic nephropathy? Macroalbuminuria Difficult to control hypertension Edema, ascites Elevated BUN and creatinine

What are the late signs of diabetic nephropathy? Less need for anti-diabetic medications Nausea and vomiting Weakness and pallor

When should you refer a patient with diabetic nephropathy to a nephrologist? When albuminuria is first detected even if BUN and creatinine are normal!! Very important to intervene early to prevent progression to renal failure

Take home messsages Screening for microalbuminuria is the most effective way of detecting early diabetic nephropathy Early diagnosis is extremely important because it is possible to retard progression of renal disease

Take home messsages ACE inhibitors or angiotensin receptor blockers must be given in all patients with diabetic nephropathy!! You must think of the nephrologist not as someone you refer to because your patient has kidney failure but someone you refer to so that your patient will not develop kidney failure

Barangay, Municipal and District Level Screen all patients for diabetes All adults should have an FPG or casual plasma glucose every 2 years DM is diagnosed if FPG > 126 mg/dl (7 mmol/L) or CPG > 200 mg/dl (11.1 mmol/L), documented twice Refer all newly diagnosed diabetics for initial work-up Reinforce compliance with therapeutic lifestyle changes

Barangay, Municipal and District Level Monitor and encourage compliance with prescribed diabetic medications Monitor patient to check whether therapeutic goals are being achieved Refer patient if therapeutic goals are not achieved or patient develops new symptoms

Provincial Level Perform initial laboratory work-up recommended for all newly diagnosed diabetics Refer patients identified to have target organ damage to the appropriate specialist

Regional and Specialty Hospital Level Assess for presence of and severity of target organ damage For those with renal abnormalities, a nephrologist should formulate a management plan to improve renal status and/or prevent further kidney damage